Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,908 | 139 | 97.3% |
| Education | $79.99 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $447.51 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $446.69 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $288.83 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $271.01 | 10 | $0 (2024) |
| PFIZER INC. | $269.23 | 13 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $237.01 | 10 | $0 (2024) |
| Amgen Inc. | $184.56 | 8 | $0 (2024) |
| Abbott Laboratories | $177.35 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $163.44 | 7 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $100.55 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,015 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($167.18) |
| 2023 | $987.65 | 50 | AstraZeneca Pharmaceuticals LP ($188.00) |
| 2022 | $843.89 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($172.54) |
| 2021 | $141.77 | 7 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($48.55) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Vascular | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $42.93 | General |
| Category: Not Applicable | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $38.52 | General |
| Category: Not Applicable | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.60 | General |
| 05/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: DIABETES | ||||||
| 05/10/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Cardiovascular | ||||||
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $1.96 | General |
| Category: Cardiovascular | ||||||
| 05/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/29/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 101 | 120 | $14,207 | $5,058 |
| 2022 | 2 | 57 | 77 | $9,665 | $3,274 |
| 2021 | 1 | 22 | 32 | $3,360 | $1,488 |
| 2020 | 1 | 31 | 43 | $4,515 | $2,054 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 47 | $7,050 | $2,419 | 34.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 13 | $2,960 | $1,006 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $2,750 | $911.79 | 33.2% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 11 | 11 | $880.00 | $423.17 | 48.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 15 | $220.00 | $126.00 | 57.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 12 | $204.00 | $99.48 | 48.8% |
| 83735 | Magnesium level | Office | 2023 | 11 | 11 | $143.00 | $72.27 | 50.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 63 | $8,715 | $2,920 | 33.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 14 | $950.00 | $354.62 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 32 | $3,360 | $1,488 | 44.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 43 | $4,515 | $2,054 | 45.5% |
About Dale Webster, NP
Dale Webster, NP is a Acute Care healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992790372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dale Webster, NP has received a total of $2,988 in payments from pharmaceutical and medical device companies, with $1,015 received in 2024. These payments were reported across 140 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,908).
As a Medicare-enrolled provider, Webster has provided services to 211 Medicare beneficiaries, totaling 272 services with total Medicare billing of $11,874. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Albany, NY
- Active Since 09/13/2005
- Last Updated 07/24/2017
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1992790372
Products in Payments
- JARDIANCE (Drug) $416.82
- LEQVIO (Drug) $310.39
- ELIQUIS (Drug) $293.19
- Arcalyst (Drug) $237.01
- CAMZYOS (Drug) $229.93
- FARXIGA (Drug) $187.36
- Repatha (Biological) $184.56
- VERQUVO (Drug) $163.44
- MITRACLIP (Device) $157.92
- ENTRESTO (Drug) $137.12
- BRILINTA (Drug) $101.47
- LifeVest (Device) $100.55
- ONPATTRO (Drug) $72.18
- CLEVIPREX (Drug) $65.72
- General - Therapies (Device) $48.47
- Inpefa (Drug) $43.20
- KENGREAL (Drug) $29.33
- NEXLETOL (Drug) $25.90
- XARELTO (Drug) $20.79
- CARDIOMEMS (Device) $19.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Albany
Mrs. Michele Biscossi, Acnp-Cs, Ms, Rn, ACNP-CS, MS, RN
Acute Care — Payments: $61,601
Darshaney Sankhar, Np, NP
Acute Care — Payments: $3,902
Mrs. Loretta Nerney, Acnp-Bc, ACNP-BC
Acute Care — Payments: $1,424
Mr. Dewayne Cecil, Agacnp, AGACNP
Acute Care — Payments: $1,269
Melissa Andersen, Np, NP
Acute Care — Payments: $1,193
Catarina Paone, Ms Anpc, MS ANPC
Acute Care — Payments: $1,057